| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01171dc9c63f43ea835ee14656202cf9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d33f732cfdc44267b57533869de33c65 |
| publicationDate |
2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018194805-A1 |
| titleOfInvention |
Use of pentapeptide-3 kttks or hexapeptide-3 kttksf for treating degenerative joint disease |
| abstract |
Use of pentapeptide-3 KTTKS or hexapeptide-3 KTTKSF for treating degenerative joint disease is disclosed. A pharmaceutical composition comprising an effective amount of pentapeptide-3 KTTKS or hexapeptide-3 KTTKSF and a pharmaceutically acceptable carrier is also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111632128-A |
| priorityDate |
2017-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |